[Orphan drugs].

J, Kolár; M, Chalabala; H, Srámková

Found an issue? Give us feedback

Česká a slovenská fa...arrow_drop_down

Česká a slovenská farmacie

Article . 2001

Data sources: Europe PubMed Central

[Orphan drugs].

descriptionPublicationkeyboard_double_arrow_right Article 10 May 2001 Czech Journal:Ceska a Slovenska farmacie : casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti, volume 50 (issn: 1210-7816,

Copyright policy )

Authors: J, Kolár; M, Chalabala; H, Srámková;

pmid: 11288591

[Orphan drugs].

- Summary
- Subjects
- Metrics

Abstract

The paper discusses the problems of orphan drugs from the standpoint of the attitude of state authorities in the USA, Japan, and particularly Europe (the European Union) to their definition and the formation of appropriate legislation--financial provision for the development, production, provision of exclusive sale rights--which warranties the availability of the drug to every patient suffering from a rare disease.

Related Organizations

TERI University
India

Keywords

Drug Industry, Japan, Orphan Drug Production, Health Policy, European Union, United States

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	0
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average